In-vitro diagnostic (IVD) solutions player Zhejiang Pushikang Biotechnology Co., Ltd. has pocketed ‘millions of dollars’ in a Series B round of financing led by YuanBio Venture Capital (also known as bioVenture), according to an announcement on Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
